Ligand Pharmaceuticals, Inc. (LGND)

197.85 +1.79 (+0.91%) USD  |  NASDAQ  |  Feb 27, 16:00
198.26 +0.42 (+0.21%) After-Hours: 20:00
More

Ligand Pharmaceuticals Free Cash Flow : 38.04M for Dec. 31, 2025

Free Cash Flow Chart

View Free Cash Flow for LGND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Johnson & Johnson 19.70B
Merck & Co., Inc. 12.36B
ADMA Biologics, Inc. 27.50M
Elanco Animal Health, Inc. 284.00M
Ionis Pharmaceuticals, Inc. -325.67M

Free Cash Flow Related Metrics

Cash from Operations (Quarterly) 45.92M
Cash from Investing (Quarterly) -18.10M
Cash from Financing (Quarterly) 8.33M
Free Cash Flow Per Share (Quarterly) 2.141
Free Cash Flow to Equity (Quarterly) 44.76M
Free Cash Flow to Firm (Quarterly) 46.66M
Free Cash Flow Yield 0.95%
Register to Continue Using YCharts

Access quality data, powerful visualization tools, and advanced analytics to make smarter investment decisions.

Unlock My Access No credit card required.

Already a subscriber? Sign in.